Deoxygenation of sickle cells stimulates Syk tyrosine kinase and inhibits a membrane tyrosine phosphatase.
Polymerization of hemoglobin S in sickle red cells, in deoxygenated conditions, is associated with K+ loss and cellular dehydration. It was previously reported that deoxygenation of sickle cells increases protein tyrosine kinase (PTK) activity and band 3 tyrosine phosphorylation and that PTK inhibitors reduce cell dehydration. Here, the study investigates which PTKs are involved and the mechanism of their activation. Deoxygenation of sickle cells induced a 2-fold increase in Syk activity, measured by autophosphorylation in immune complex assays, but had no effect on Lyn. Syk was not stimulated by deoxygenation of normal red cells, and stimulation was partly reversible on reoxygenation of sickle cells. Syk activation was independent of the increase in intracellular Ca++ and Mg2+ associated with deoxygenation. Lectins that promote glycophorin or band 3 aggregation did not activate Syk. In parallel to Syk stimulation, deoxygenation of sickle cells, but not of normal red cells, decreased the activity of both membrane-associated protein tyrosine phosphatase (PTPs) and membrane protein thiol content. In vitro pretreatment of Syk immune complexes with membrane PTP inhibited Syk autophosphorylation. It is suggested that Syk activation in vivo could be mediated by PTP inhibition, itself resulting from thiol oxidation, as PTPs are known to be inhibited by oxidants. Altogether these data indicate that Syk could be involved in the mechanisms leading to sickle cell dehydration.
Merciris
P
P
Biomembranes et Messagers Cellulaires, Université Paris XI-Orsay, France.
Hardy-Dessources
M D
MD
Giraud
F
F
D000755:Anemia, Sickle Cell / Q000097:blood* / Q000201:enzymology; D000936:Antigen-Antibody Complex / Q000187:drug effects; D002118:Calcium / Q000097:blood; D003890:Desiccation; D004789:Enzyme Activation / Q000187:drug effects; D004792:Enzyme Precursors / Q000097:blood* / Q000276:immunology; D004913:Erythrocytes, Abnormal / Q000187:drug effects / Q000201:enzymology*; D005978:Glutathione / Q000097:blood; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008274:Magnesium / Q000097:blood; D008565:Membrane Proteins / Q000037:antagonists & inhibitors* / Q000097:blood; D010084:Oxidation-Reduction; D010100:Oxygen / Q000097:blood / Q000494:pharmacology*; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors* / Q000097:blood; D011505:Protein-Tyrosine Kinases / Q000097:blood* / Q000276:immunology; D013438:Sulfhydryl Compounds / Q000097:blood; D000072377:Syk Kinase; D019061:src-Family Kinases / Q000097:blood / Q000276:immunology
D000936:Antigen-Antibody Complex; D004792:Enzyme Precursors; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D013438:Sulfhydryl Compounds; D011505:Protein-Tyrosine Kinases; C000606896:SYK protein, human; D000072377:Syk Kinase; C060902:lyn protein-tyrosine kinase; D019061:src-Family Kinases; D017027:Protein Tyrosine Phosphatases; D005978:Glutathione; D008274:Magnesium; D010100:Oxygen; D002118:Calcium